Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/5/26 19:42 | 10/2/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Venker Eric | NC | DO | CEO | 1 | S.d | -120 | 34.11 | 0 | -4 | 257 | D | |||||||||||||||
9/25/26 16:05 | 9/23/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Van Tuyl Christopher | NC | O | GC | 1 | S | -103 | 36.36 | 0 | -3 | 177 | D | |||||||||||||||
8/28/26 16:27 | 8/28/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Pande Atul | NC | D | 2 | S.d | -125 | 41.54 | 0 | -3 | 137 | D | ||||||||||||||||
8/21/26 16:03 | 8/20/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Gloria Melanie | NC | O | COO | 1 | S | -135 | 44.16 | 0 | -3 | 219 | D | |||||||||||||||
7/24/26 17:57 | 7/23/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Girao Tiago | NC | O | CFO | 1 | S | -263 | 38.69 | 0 | -7 | 241 | D | |||||||||||||||
7/24/26 17:57 | 7/23/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NC | O | CTO | 1 | S | -111 | 38.69 | 0 | -3 | 205 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |